ZA951235B - 1-[2-(1H-inden-3-YL)ethyl]-4-(naphth-1-yl) piperazine derivatives their preparation and their application in therapeutics - Google Patents

1-[2-(1H-inden-3-YL)ethyl]-4-(naphth-1-yl) piperazine derivatives their preparation and their application in therapeutics

Info

Publication number
ZA951235B
ZA951235B ZA951235A ZA951235A ZA951235B ZA 951235 B ZA951235 B ZA 951235B ZA 951235 A ZA951235 A ZA 951235A ZA 951235 A ZA951235 A ZA 951235A ZA 951235 B ZA951235 B ZA 951235B
Authority
ZA
South Africa
Prior art keywords
naphth
inden
therapeutics
ethyl
preparation
Prior art date
Application number
ZA951235A
Other languages
English (en)
Inventor
Philippe Manoury
Michel Peynot
Pascal George
Daniel Obitz
Mireille Sevrin
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of ZA951235B publication Critical patent/ZA951235B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA951235A 1994-02-16 1995-02-15 1-[2-(1H-inden-3-YL)ethyl]-4-(naphth-1-yl) piperazine derivatives their preparation and their application in therapeutics ZA951235B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9401736A FR2716193B1 (fr) 1994-02-16 1994-02-16 Dérivés de 1[2-(1h-inden-3-yl)ethyl]-4-(naphtalen-1-yl)piperazine, leur préparation et leur application en thérapeutique.

Publications (1)

Publication Number Publication Date
ZA951235B true ZA951235B (en) 1996-01-18

Family

ID=9460124

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA951235A ZA951235B (en) 1994-02-16 1995-02-15 1-[2-(1H-inden-3-YL)ethyl]-4-(naphth-1-yl) piperazine derivatives their preparation and their application in therapeutics

Country Status (18)

Country Link
US (1) US5530002A (no)
EP (1) EP0668273A1 (no)
JP (1) JPH07252243A (no)
KR (1) KR950032160A (no)
CN (1) CN1112554A (no)
AU (1) AU680327B2 (no)
CA (1) CA2142535A1 (no)
CZ (1) CZ39395A3 (no)
FI (1) FI950670A (no)
FR (1) FR2716193B1 (no)
HU (1) HUT71898A (no)
IL (1) IL112661A0 (no)
NO (1) NO304230B1 (no)
NZ (1) NZ270500A (no)
PL (1) PL307286A1 (no)
RU (1) RU95102147A (no)
SK (1) SK20795A3 (no)
ZA (1) ZA951235B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737724B1 (fr) * 1995-08-09 1997-09-05 Synthelabo Derives de 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4- (naphtalen-1-yl) piperazine, leur preparation et leur application en therapeutique
FR2737723B1 (fr) * 1995-08-09 1997-09-05 Synthelabo Derives de 1-(2-(1h-inden-3-yl)ethyl)-4-(naphtalen-1-yl)- piperazine, leur preparation et leur application en therapeutique
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
PT1831159E (pt) * 2004-12-21 2010-03-03 Hoffmann La Roche Derivados de tetralina e de indano e as suas utilizações

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130646A (en) * 1975-07-25 1978-12-19 E. R. Squibb & Sons, Inc. 1,2,3,4-Tetrahydro-2-((4-(phenyl)-1-piperazinyl)methyl)-1-naphthalenols and derivatives and analogs thereof
US4845221A (en) * 1988-04-15 1989-07-04 American Home Products Corporation Serotonergic substituted piperazinyl tetralins
FR2670491B1 (fr) * 1990-12-14 1993-02-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
IT1255178B (it) * 1992-06-26 1995-10-20 Pierrel Spa N(eter0)-aril-n(etero)-tetralinalchil piperazine aventi attivita' serotoninergica,dopaminergica e adrenergica

Also Published As

Publication number Publication date
FI950670A0 (fi) 1995-02-15
NO950560L (no) 1995-08-17
US5530002A (en) 1996-06-25
CA2142535A1 (en) 1995-08-17
AU680327B2 (en) 1997-07-24
FI950670A (fi) 1995-08-17
RU95102147A (ru) 1996-12-10
NZ270500A (en) 1996-02-27
NO304230B1 (no) 1998-11-16
KR950032160A (ko) 1995-12-20
JPH07252243A (ja) 1995-10-03
HUT71898A (en) 1996-02-28
PL307286A1 (en) 1995-08-21
FR2716193A1 (fr) 1995-08-18
CZ39395A3 (en) 1995-10-18
FR2716193B1 (fr) 1996-04-05
IL112661A0 (en) 1995-05-26
NO950560D0 (no) 1995-02-15
HU9500453D0 (en) 1995-03-28
AU1224495A (en) 1995-08-24
EP0668273A1 (fr) 1995-08-23
CN1112554A (zh) 1995-11-29
SK20795A3 (en) 1995-09-13

Similar Documents

Publication Publication Date Title
PL314135A1 (en) Heteroaryl piperidines, pyrolydines and piperazines and their application as antipsychotic and analgetic agents
IL107132A0 (en) Piperidine derivatives,their preparation and their application in therapeutics
IL112249A0 (en) Heterocyclic pyrimidine derivatives and pharmaceutical compositions containing them
HU9503045D0 (en) Heterocyclic compounds and their preparation and use
GB9515775D0 (en) Piperidine derivatives and their use as therapeutic agents
NZ328387A (en) 4-[2-(n-(heteroaryl)-hydrazonoethyloxy)]benzoyl-2-benzyloxy-carbonylamino-alanine derivatives and medicaments containing them
HUP9904167A3 (en) 1,4-disubstituted piperazine and piperidine derivatives, their use and pharmaceutical compositions containing the same
NZ325845A (en) 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives, preparation and pharmaceutical use thereof
HU9802129D0 (en) New piperazine and piperidine derivatives
ATE204177T1 (de) Verwendung von substanz p antagonist im pharmazeutischer zusammensetzung
ZA961994B (en) Piperidine derivatives process for the preparation thereof and application thereof in therapeutics
AU6524996A (en) Piperazine derivatives and their use as 5-HT1A antagonists
ZA952410B (en) Substituted heterocyclic carboxamioesters their preparation and their use as pharmaceuticals
ZA951235B (en) 1-[2-(1H-inden-3-YL)ethyl]-4-(naphth-1-yl) piperazine derivatives their preparation and their application in therapeutics
IL99779A0 (en) 1-(3,4-dihydro-2-oxo-1h-quinolin-6-yl)-2-(4-(2-phenylethyl)piperidin-1-yl)ethanol and-ethanone,their preparation and their therapeutic application
IL123187A0 (en) 1-[2-(2,3-dihydro-1H-inden-1-yl)ethyl]-4-(naphth-1-yl)piperazine derivatives their preparation and their application in their therapeutics
IL110963A0 (en) 1[2-amino-5-[1-(triphenylethyl)-1h-imadazol-4-yl]-1- oxopentyl] piperidine derivatives, their preparation and their use as synthetic intermediates
ZA94910B (en) New heterocyclic 4-(aminomethyl) piperidine derivatives preparations thereof and application thereof in therapeutics
ZA944573B (en) Piperidines and piperazines
GB2290955B (en) Folding frame for flat top furniture
GB2286392B (en) Piperazine derivatives and pharmaceutical uses thereof
ZA985518B (en) 4-[(1H-imidazol-4-YL) piperidin-1-YL] anilide derivatives their preparation and their application in therapeutics
ZA985727B (en) (1H-imidazol-4-YL) piperidine derivatives their preparation and their application in therapeutics
GB9404135D0 (en) Improvement in or relating to hinges
ZA948501B (en) Heteroarylpiperidines pyrrolidines and piperazines and their use as antipsychotics and analgetics